Breaking News
0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Fiona Cincotta

  • Analysis & Opinion

Fiona Cincotta's Opinion & Analysis
A complete archive of Fiona Cincotta's articles, including current analysis & opinion - Page 2

Vaccine trials restart Over the weekend, Oxford University announced that the joint AstraZeneca (NYSE:AZN) COVID vaccine trial will restart this week after a routine pause n the previous week. News...
Overnight the tech-heavy NASDAQ reported its strongest rise in over 4 months, surging 2.7% snapping a three-day losing streak which had traders questioning the valuations of big tech stocks. The Dow...
Wall Street rolled on with another record day. The S&P hit its fourth straight closing high and the Nasdaq set its 39th closing high YTD as investors remained focused on big tech and large cap...
European bourses hobbled into the close on Tuesday. Meanwhile Wall Street opted for a different route with both the S&P and the NASDAQ pushing to fresh record closes—again.   With US coronavirus...
Markets both in the US and Europe saw a solid start to the week. On Wall Street, the S&P and the NASDAQ closed at a record-high. Coronavirus vaccine and treatment developments hopes of additional...
Trading has kicked off the new week on the front foot thanks to vaccine optimism after the FDA approved the use of blood plasma from recovered patients as a COVID treatment option for coronavirus...
European bourses are looking towards a lower start to trading on Wednesday, following on from a choppy session in Asia amid rising uncertainty over whether US lawmakers will agree to an additional...
As expected, the BoE kept monetary policy on hold with interest rates at the historically low levels of 0.1%. This meant that the quarterly inflation report and the tone of the central bank would...
After an upbeat close on Wall Street, European markets are pointing to a stronger start. A combination of slowing new coronavirus cases in the US, vaccine optimism from Novavax (NASDAQ:NVAX) and a...
Better than forecast US manufacturing data calmed fears that the rising number of coronavirus cases there was hampering the economic recovery. Whilst this is just the first data point of many this...